Druggists Companies in Malaysia

The Malaysian government has identified the pharmaceutical and medical device industries as key growth areas in the country’s economy. As a result, a number of incentives have been put in place to attract foreign investment in these sectors.

One of the most attractive incentives for foreign investors is the Malaysian Investment Development Authority’s (MIDA) 100% foreign equity ownership policy for manufacturing projects in the pharmaceutical and medical device industries. This policy allows foreign companies to fully own their manufacturing operations in Malaysia, giving them greater control over their business.

In addition, the Malaysian government has also put in place a number of tax incentives for companies operating in the pharmaceutical and medical device industries. These incentives include a 10-year income tax exemption for new manufacturing projects and a 5-year income tax exemption for expanding existing manufacturing projects.

The Malaysian government’s efforts to attract foreign investment in the pharmaceutical and medical device industries are paying off. A number of major international companies have already set up operations in Malaysia, including Pfizer, GlaxoSmithKline, and Johnson & Johnson.